KRAS inhibitor-16 structure
|
Common Name | KRAS inhibitor-16 | ||
|---|---|---|---|---|
| CAS Number | 2230873-67-1 | Molecular Weight | 452.33 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H16Cl2FN3O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS inhibitor-16KRAS inhibitor-16 (compound 3-11) is a potent KRAS G12C inhibitor with an IC50 of 0.457 µM. KRAS inhibitor-16 shows p-ERK inhibition activities with IC50s of 3.06, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-16 has the potential for the research of pancreatic, colorectal, and lung cancers[1]. |
| Name | KRAS inhibitor-16 |
|---|
| Description | KRAS inhibitor-16 (compound 3-11) is a potent KRAS G12C inhibitor with an IC50 of 0.457 µM. KRAS inhibitor-16 shows p-ERK inhibition activities with IC50s of 3.06, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-16 has the potential for the research of pancreatic, colorectal, and lung cancers[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12C:0.457 μM (IC50) |
| References |
[1]. Brian Alan LANMAN, et al. Kras g12c inhibitors and methods of using the same. US20180334454A1. |
| Molecular Formula | C20H16Cl2FN3O2S |
|---|---|
| Molecular Weight | 452.33 |